Transitional Drugs 7

View buyer

Estimated value

Awarded value

£16.8m

Awarded 03 Jun 2026

Suppliers

10

Lots

1

1 awarded

Published

05 Jun 2026

Description

Supply of Transitional Drugs 7

Scope

Reference
PHA-FTS-62154
Commercial tool
Standalone contract
Contract dates
30 Jun 2026 to 30 Jun 2028
Possible extension to 30 Jun 2030

Extension option of up to 2 years available.

CPV classifications
33600000
Contract locations
Wales, United Kingdom
Particular suitability
Small and medium-sized enterprises (SME)

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
Product Quality/AcceptabilityPass/Failquality1.00%
Financial (Overall Cost of Contract)Weighting:85cost2.00%
Environmental/Social Value/Community BenefitsWeighting :15quality3.00%

Participation

Conditions suppliers must meet to bid.

As per the tender documents.

Submission & procedure

Procedure
Open procedure

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£16.8m

Award date

03 Jun 2026

Contract start

30 Jun 2026

Contract end

30 Jun 2028